Lily Dolatshahi, Amani Ashraf
Immune thrombocytopenia (ITP) is one of the most common acquired bleeding disorders. ITP is characterized by a low platelet count in the setting of a normal hemoglobin and white blood cell count. ITP classifications are dependent on inciting factors and duration of the episodes. The management of ITP is usually guided on severity of symptoms, with life-threatening bleeding prompting the most extensive response. However, there is also a push to treat symptoms of ITP that affect quality of life. Understanding, diagnosing, and treating patients with ITP requires expertise in the rapidly growing field of autoimmune disorders.